Pr ecis: This study shows how new NAD-depleting drugs offer a way to leverage the efficacy of clinical agents that target dihydrofolate reductase, used widely in the oncology clinic, in deadly lung adenocarcinomas Pr ecis: This clinical study illuminates a connection between the pattern of effects in peripheral neuropathy, a major scourge of successful cancer treatment, with the specific nerve fiber types most vulnerable to cytotoxic chemotherapy, with important implications for how to focus future work to ameliorate risks of this important survivor challenge.
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Vaccine Pr ecis: This study provides a preclinical proof of concept for the repositioning of gamma-secretase inhibitors, previously evaluated in clinical trials, as a new treatment for aggressive esophageal cancers.
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ABOUT THE COVER
Astrocyte elevated gene-1 (AEG-1) is an oncogene that is overexpressed in all cancers. Although the oncogenic function of AEG-1 has been studied in tumor cells, as yet the role of AEG-1 in tumor microenvironment cells has not been analyzed. Using immunofluorescence it was documented that AEG-1 is expressed at a high level in macrophages, and functional studies documented that macrophage AEG-1 plays an important role in regulating NF-kB activation and thereby initiation of hepatocarcinogenesis. For details, see article by Robertson and colleagues on page 6184. To request permission to re-use all or part of this article, contact the AACR Publications Department at
